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Genomic DNA PCR analysis to assess xenograft 
development in mouse mammary gland
Etienne Aujean1, Johann Laubier1, Nicolas Brun1, Laurence Finot2, Eric Chanat2, Frédéric Dessauge2, Cathy Hue-Beauvais1 & Fabienne Le 
Provost*,1
ABSTRACT
The mouse transplantation model 
remains the most relevant method-
ology to assess the functional 
capacities of mammary cells and is 
particularly appropriate for investi-
gations regarding mammary stem 
cells, whatever the species studied. 
Following xenotransplantation in 
mice mammary fat pad, the devel-
opment of the xenograft is commonly 
evaluated by immunohistology. Here, 
we present a simple and rapid method 
to control the species specificity of 
a xenograft based on genomic DNA 
PCR amplification. DNA is extracted 
from the fixed samples intended for 
histology, thus allowing the reuse 
of precious samples. Standard and 
digital droplet PCR (requiring low DNA 
quantities) methods have been used 
to make the present method suitable 
for the analysis of xenotransplanted 
samples.
METHOD SUMMARY
A new approach to estimate the 
species specificity of xenografts is 
described. This method is based on 
PCR amplification of genomic DNA 
samples extracted from mammary 
tissue that has been processed for 
histological analyses, such as whole 
mounts, paraffin blocks and sections.
When studying epithelial cell lineages and 
stem cells of the mammary gland, the 
mammary transplantation approach is 
recognized as the most relevant technology 
for testing the capacities of the isolated cells 
or explants to reconstitute a functional 
organ [1,2]. This method consists of trans-
plantation of mammary explants or sorted 
cells in cleared mouse mammary fat pad [3] 
and is widely used to characterize mouse 
mammary epithelial cells, particularly the 
stem and progenitor cell populations. More 
recently, xenotransplantation experiments 
have been extended to studies involving 
mammary stem cells from species such as 
humans and cattle [4–6]. However, in 
xenotransplantation assays, it is critically 
important to confirm that the developing 
tissue belongs to the species of origin. 
Kuperwasser et  al. [4] performed this 
species-specificity control through immuno-
histochemistry with specific anti-human 
antibodies, as well as genomic FISH 
analyses. Unfortunately, specific antibodies 
to bovine proteins are scarce; therefore, 
mouse antibodies have been used in some 
cases to characterize bovine xenotrans-
plants [6,7]. The lack of specific immuno-
logical tools for species such as bovine can 
make the results of xenograft development 
difficult to interpret. The PCR method could 
be used to detect transplanted cells using 
DNA extracted from frozen tissue [8,9]. Here, 
we propose an alternative method to 
determine the species-specific mammary 
tissue that develops after xenotransplan-
tation using genomic DNA extracted from 
fixed tissue. This method can be applied 
regardless of the species of the graft of 
origin and independently of the immuno-
logical analysis.
The method was developed to charac-
terize the ability of the bovine-transplanted 
samples to generate mammary epithelium. 
Mouse mammary glands were collected 
8 weeks after transplantation, and whole 
mounts were carried out. Briefly, the 
mammary tissues were excised from eutha-
nized mice, spread on glass slides, fixed in 
Carnoy’s solution (ethanol, chloroform and 
glacial acetic acid in a 6:3:1 ratio) overnight at 
room temperature, and rehydrated gradually. 
The tissues were stained with Carmin alum 
solution for 1.5 h at 4°C, dehydrated, cleared 
in xylene or ESTISOL™ (Estichem A/S, 
Gadstrup, Denmark) solution and mounted 
using Permount™ (Thermo Fisher Scientific, 
MA, USA) mounting medium. After image 
acquisitions, tissues present in the whole 
mounts were either used for DNA extraction 
or embedded in paraffin blocks, sectioned 
(5-μm thick sections) and stained with 
hematoxylin and eosin solution.
To extract the genomic DNA from 
tissues present in whole mounts, samples 
were dismounted in xylene, then rehydrated 
and dried at room temperature. To extract 
the genomic DNA from paraffin blocks or 
sections, the part containing the tissue was 
cut manually with a scalpel. The paraffin was 
then removed in xylene, and collected tissue 
pieces were washed in 100% ethanol and dried 
at room temperature. For all samples, tissue 
was incubated in 500 μl (small pieces, ≤1 cm2) 
to 1 ml (entire gland) of lysis buffer (100-mM 
Tris, 5-mM EDTA, 0.2% SDS, 0.2-M NaCl; 
pH 7.4) supplemented with 1% proteinase 
K (20 mg/ml) at 37°C for 3 h to overnight 
according to the tissue size. After centrifu-
gation (10 min at 13,000×g), the supernatant 
was collected, supplemented with 1 volume 
of isopropanol and centrifuged as above. The 
resulting pellet was dried and suspended in 
50 μl of 10-mM Tris and 0.1-mM EDTA buffer. 
DNA quality and quantity were assessed by 
loading an aliquot in 0.8% agarose gel and 
by the absorbance determination at 230, 260 
and 280 nm using a NanoDrop™ spectropho-
tometer (Thermo Fisher Scientific).
As the clearing process may impact 
genomic DNA quality, we compared two 
clearing protocols using xylene (X) or 
ESTISOL (E) solutions. For this test, DNA 
extractions were performed using mammary 
gland whole mounts from control mice 
(Figure 1A) and the phenol-chloroform 
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Figure 1. Analysis of the genomic DNA extracted from mouse mammary gland transplanted with mouse mammary explants. (A) Whole mount cleared 
by X or E solutions. (B) Electrophoretic assessment of genomic DNA (1-μg loads) extracted from whole mounts cleared by either X or E solutions. (C) 
Amplification of the murine Actb and B2m genes from genomic DNA extracted from whole mounts cleared by either X or E solutions. (D) Amplification of 
murine B2m gene from genomic DNA extracted from paraffin-embedded tissue (Mu-Bl).
CoM: Control using mouse genomic DNA extracted from tail; CoNeg: Negative control without genomic DNA; E: ESTISOL; M: Promega 1-Kb ladder size 
marker in part (B); M: Promega bench-top 100-bp (Promega) size marker in parts (C) and (D); X: Xylene.
extraction protocol. In both cases, the quality 
(Figure 1B) and quantity (620 μg/sample) 
of DNA were equivalent; therefore, xylene 
clearing was further used because it was the 
most efficient. Mouse Actb and B2m gene 
primers (Table 1) allowed the amplification 
of PCR products of 350 and 120 bp, respec-
tively, from DNA (100 ng) extracted from 
mouse mammary gland whole mounts 
by standard PCR (45 cycles) (Figure 1C). 
In contrast, genomic DNA extracted from 
paraffin-embedded tissues or sections (3–5 
sections per sample) was degraded (Supple-
mentary Figure 1) but did allow amplification 
of fragments of small size, such as 120 bp 
(using the B2m primers) (Figure 1D), but not 
amplification of fragments 350 bp in length 
(using the Actb primers; data not shown). 
In order to detect the presence of 
exogenous DNA in xenotransplanted mice, 
DNA extraction was performed using mouse 
mammary transplanted with bovine samples 
(Figure 2A and Supplementary Figure 1). 
PCR amplifications of species-specific 
genes were performed on genomic DNA 
extracted from tissues embedded in paraffin: 
murine B2m gene and bovine Mtx2 and 
Twf1 genes (Table 1). DNA amplifications 
were carried out using primers chosen 
to amplify small fragments (120 bp). The 
presence of bovine epithelial development 
was confirmed by classical PCR and digital 
droplet PCR (ddPCR) methods (Figure 2 & 
Supplementary Figure 1). Because the parts 
of the mammary tissue containing the graft 
were cut manually with a scalpel under a 
binocular, they contained some mouse 
tissue. This explains the amplifications 
obtained using mouse B2m gene primers 
(Figure 2 & Supplementary Figure 1).
Although xenotransplantation is a very 
attractive tool, the rate of xenograft devel-
opment is low; hence, each sample is 
precious. In this context, the strategy reported 
here offers several advantages. Indeed, the 
graft development can be characterized by 
histology (whole-mount and hematoxylin and 
eosin staining of sections), and its species 
specificity can be assessed using the same 
sample. As graft development is sparse and 
limited, the possibility to select the part of the 
gland that contains the graft, after histological 
observation, allows further improvement of 
the DNA analysis by increasing the concen-
tration of genomic DNA contained in the graft. 
Here, we propose an alternative approach to 
immunohistological analysis: amplification 
performed on DNA extracted from various 
types of samples, such as whole mounts or 
tissue sections, and the use of standard PCR 
technology, as well as ddPCR, which requires 
lower DNA quantities.
PCR analysis of genomic DNA is faster, 
less expensive and more convenient than 
immunohistological methods. It is also more 
accurate, as species-specific antibodies are 
scarce for livestock species. Most of the 
antibodies currently available are developed 
against human or mouse proteins and do 
not cross-react with livestock species. In 
contrast, the design of species-specific 
primers is simple, and they can be developed 
for all species. Therefore, the approach 
presented here promises to remove 
important biotechnological bottlenecks.
So far xenotransplantation assays 
using human or bovine samples have been 
described in very few studies; however, the 
number of species under study is expected 
to increase in the future. Structural and 
functional characteristics of the mammary 
gland are conserved across species, but 
interspecies specificities still remain that are 
important to highlight. The establishment 
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of these particular features involves 
detailed processes of tissue development, 
including mammary stem cell differen-
tiation. In conclusion, this method repre-
sents a simple and reliable way to control 
the species of origin of the developed tissue 
during xenotransplantation assays.
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Table 1.  Sequences of primers used to perform amplifications by classical PCR and digital droplet PCR meth-
ods.
Species Gene Forward primer (5′ to 3′ end) Reverse primer (5′ to 3′ end)
Murine Actb GCTGTATTCCCCTCCATCGTG CACGGTTGGCCTTAGGGTTCAG
Murine B2m GTGACGACCTCCGGATCTGA GCCGAGTAGCAGCCACTGAA
Bovine Mtx2 AGAGTCTTGTTACCCCATCCA ACCCTTGGCCTCTGAATCAT
Bovine Twf1 CTCGCGATCACTTAACGA GTGGTGTCAAAGACTTACGAACA
ddPCR: Digital droplet PCR.
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Figure 2. Analyses of genomic DNA extracted from mouse mammary gland xenotransplanted with bovine explants. (A) WM and hematoxylin and eosin 
staining of H. Red circle shows bovine xenograft. (B) Amplification using classical PCR method of mouse B2m and bovine Twf1 and Mtx2 genes from 
genomic DNA extracted from sections MuBov-Sl, CoM and CoB. (C) Amplification using ddPCR method of mouse B2m and bovine Twf1 and Mtx2 genes 
from genomic DNA (10 ng) extracted from sections, mouse tail and bovine blood. Results are presented as gene copy number per microliter of DNA 
sample. Red numbers indicate the concentration for each sample (copy number per microliter).
CoB: Bovine blood; CoM: Mouse tail; CoNeg: Negative control without genomic DNA; ddPCR: Digital droplet PCR; H: Histological section; M: Promega 
bench-top 100-bp size marker; MuBov-Sl: Mouse mammary gland xenotransplanted with bovine explant; WM: Whole-mount.
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